Medpace (MEDP) CFO Kevin Brady Exercises Options, Sells 3,400 Shares

What Happened Kevin M. Brady, CFO & Treasurer of Medpace Holdings, exercised 3,400 stock options and immediately sold the 3,400 shares on Aug 20, 2026. The options were exercised at $138.87 per share (total cost $472,158), and the shares were sold at $625.24 per share for total proceeds of $2,125,816. The filing also shows a derivative conversion entry (3,400 shares at $0.00) reflecting the option-to-stock conversion.

Key Details

• Date of transactions: August 20, 2026
• Option exercise: 3,400 shares at $138.87 = $472,158 (code M)
• Open‑market sale: 3,400 shares at $625.24 = $2,125,816 (code S)
• Derivative conversion line: 3,400 shares at $0.00 (formal conversion entry)
• Shares owned after the transaction: not specified in the filing
• Footnotes: F1 — transactions effected pursuant to a limit order during an open window; F2 — the option vested in full on Feb 15, 2026
• Filing date: Aug 24, 2026 — filed within required reporting window (timely)

Context This is effectively a cashless exercise: Brady exercised vested options and sold the resulting shares the same day via a limit order. Such same‑day exercises followed by sales are commonly used to realize option gains or cover tax/liquidity needs; the filing is factual and does not state the insider’s motivation. Transaction codes: M = option exercise/conversion, S = sale.